Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.68 |
| ▸ | ALPI | P09923 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | XIAP | P98170 | 1/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | TPH1 | P17752 | 1/20 | 0.57 |
| ▸ | GRB2 | P62993 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL157558 | 1.00 | SLC7A5 (0.69) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL157559 | 1.00 | SLC7A5 (0.69) | SLC7A5PTGS1ALPIPKMXIAP | |
| Phenylalanine SCHEMBL20658148 | 0.92 | SLC7A5 (0.81) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL2310526 | 0.89 | SLC7A5 (0.83) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL8977526 | 0.88 | LDHA (0.63) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL8977524 | 0.88 | LDHA (0.63) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL19733537 | 0.86 | SLC7A5 (0.50) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL28653399 | 0.85 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL2496326 | 0.85 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL192235 | 0.84 | SLC7A5 (0.69) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4696699-A1 | ? OPIOID RECEPTOR AGONIST AND USE THEREOF | Chengdu Aoda Biotechnology Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4696700-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | Chengdu Aoda Biotechnology Co., Ltd (CN) | 2026-02-18 | — | — | EP | claimed |
| CN-119899240-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119390765-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| WO-2024212866-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | 成都奥达生物科技有限公司 | 2024-10-17 | — | — | WO | claimed |
| WO-2024212865-A1 | κ OPIOID RECEPTOR AGONIST AND USE THEREOF | 成都奥达生物科技有限公司 | 2024-10-17 | — | — | WO | claimed |
| CN-118772231-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-5486596-A | CYCLIC PEPTIDES | CESKOSLOVENSKA AKADEMIE VED (CS) | 1996-01-23 | — | — | US | claimed |
| EP-0412508-B1 | Analogues of vasopressin, their preparation and pharmaceutical use | CESKOSLOVENSKA AKADEMIE VED (CS) | 1995-07-05 | — | — | EP | claimed |
| EP-0412508-A1 | Analogues of vasopressin, their preparation and pharmaceutical use | CESKOSLOVENSKA AKADEMIE VED (CS) | 1991-02-13 | — | — | EP | claimed |
| JP-3128395-A | — | — | None | — | — | JP | disclosed |
| US-20260049060-A1 | TETRAHYDROISOQUINOLINYLMETHYLBENZAMIDE COMPOUNDS | NATIONAL HEALTH RES INST (TW) | 2026-02-19 | — | — | US | disclosed |
| EP-4696699-A1 | ? OPIOID RECEPTOR AGONIST AND USE THEREOF | Chengdu Aoda Biotechnology Co., Ltd. (CN) | 2026-02-18 | — | — | EP | disclosed |
| EP-4696700-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | Chengdu Aoda Biotechnology Co., Ltd (CN) | 2026-02-18 | — | — | EP | disclosed |
| CN-119899240-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| EP-0412508-B1 | Analogues of vasopressin, their preparation and pharmaceutical use | CESKOSLOVENSKA AKADEMIE VED (CS) | 1995-07-05 | — | — | EP | disclosed |
| JP-H03128395-A | 8-D-HOMOARGININE-VASOPRESSIN ANALOG | CESKOSLOVENSKA AKAD VED | 1991-05-31 | — | — | JP | disclosed |
| EP-0412508-A1 | Analogues of vasopressin, their preparation and pharmaceutical use | CESKOSLOVENSKA AKADEMIE VED (CS) | 1991-02-13 | — | — | EP | disclosed |
| EP-0412508-A1 | Analogues of vasopressin, their preparation and pharmaceutical use | CESKOSLOVENSKA AKADEMIE VED (CS) | 1991-02-13 | — | — | EP | disclosed |
| US-4483794-A | UROGENITAL MUSCLE RELAXANT | CESKOSLOVENSKA AKADEMIE VED (CS) | 1984-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049060-A1 | TETRAHYDROISOQUINOLINYLMETHYLBENZAMIDE COMPOUNDS | OPRK1, OPRD1, OPRM1 | SLC7A5 2400/4885PTGS1 405/4885ALPI 3775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.